PRISCILLA STYONS: Open Payments
NPI 1174244339 · WASHINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 12 payments from 5 companies in 2025. Trend: 2023 $698 · 2024 $531 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 4 | $96 |
| ABBVIE INC. | 4 | $68 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: INVEGA SUSTENNA, VRAYLAR, COBENFY, CAPLYTA, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
